Curanex Pharmaceuticals Inc
CURX
$0.63
$0.022.84%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 57.70K | 137.50K | 63.90K | 102.10K | 44.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.70K | 137.50K | 63.90K | 102.10K | 44.20K |
| Operating Income | -57.70K | -137.50K | -63.90K | -102.10K | -44.20K |
| Income Before Tax | -60.30K | -137.60K | -137.20K | -99.90K | -44.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -60.30K | -137.60K | -137.20K | -99.90K | -44.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.30K | -137.60K | -137.20K | -99.90K | -44.20K |
| EBIT | -57.70K | -137.50K | -63.90K | -102.10K | -44.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | -0.01 | -0.01 | 0.00 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | 0.00 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 24.00M | 24.00M | 24.08M | 24.16M | 2.40M |
| Average Diluted Shares Outstanding | 24.00M | 24.00M | 24.08M | 24.16M | 2.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |